Latigo Biotherapeutics, Inc. (LTGO)Healthcare | Biotechnology | Thousand Oaks, United States | NasdaqGS
24.23 USD
-0.77
(-3.080%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 24.23 |
Hot Take ↕ | Aug. 22, 2026, 4:13 a.m. EDT
The immediate outlook is neutral due to a lack of statistical data to confirm momentum, despite a recent price bounce off the lows. However, the long-term investment case is severely compromised by deteriorating fundamentals: the company reports negative book value, negative operating cash flow, and negative earnings per share, indicating a business that is currently destroying capital rather than generating it. Furthermore, the absence of any dividend history confirms there is no income component to offset these risks. With no recent news catalysts and a complete lack of price history to validate a recovery thesis, the security presents a high-risk profile with no clear path to value creation. |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 1.539 |
| Market Cap | 1,532,257,536 |
| Website | https://latigobio.com |
| Attribute | Value |
|---|---|
| 52 Week Change | 0.3276713 |
| Address1 | 1,300 Rancho Conejo Boulevard |
| Address2 | Suite 305 |
| All Time High | 25.93 |
| All Time Low | 17.22 |
| Ask | 24.77 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 185,070 |
| Average Daily Volume3 Month | 423,375 |
| Average Volume | 423,375 |
| Average Volume10Days | 185,070 |
| Bid | 24.39 |
| Bid Size | 1 |
| Book Value | -42.494 |
| City | Thousand Oaks |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 24.23 |
| Current Ratio | 3.233 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 25.62 |
| Day Low | 24.23 |
| Debt To Equity | 1.539 |
| Display Name | Latigo Biotherapeutics |
| Ebitda | -112,087,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -3.488 |
| Enterprise Value | 390,977,696 |
| Eps Trailing Twelve Months | -2.47 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 21.0125 |
| Fifty Day Average Change | 3.2174988 |
| Fifty Day Average Change Percent | 0.15312308 |
| Fifty Two Week Change Percent | 32.767128 |
| Fifty Two Week High | 25.93 |
| Fifty Two Week High Change | -1.7000008 |
| Fifty Two Week High Change Percent | -0.06556115 |
| Fifty Two Week Low | 17.22 |
| Fifty Two Week Low Change | 7.01 |
| Fifty Two Week Low Change Percent | 0.40708482 |
| Fifty Two Week Range | 17.22 - 25.93 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,786,109,400,000 |
| Float Shares | 1,755,922 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 59 |
| Fullday Change | -0.77 |
| Fullday Change Percent | -3.08 |
| Fullday Price | 24.23 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.05485 |
| Held Percent Institutions | 0.82989997 |
| Implied Shares Outstanding | 63,238,030 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,026-08-07 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Latigo Biotherapeutics, Inc. develops non-opioid pain medicines designed to stop the transmission of pain without the risk of addiction. The company's pipeline includes LTG-001, an oral NaV1.8 inhibitor designed to provide fast-acting, opioid-sparing relief for the treatment of acute pain; LTG-321, a NaV1.8 inhibitor candidate developed for the treatment of chronic musculoskeletal pain, starting with osteoarthritis; and LTG-418, a NaV1.8 inhibitor developed for the treatment of acute and chronic pain. Latigo Biotherapeutics, Inc. was formerly known as WVB-Desmond, Inc. and changed its name to Latigo Biotherapeutics, Inc. in March 2019. Latigo Biotherapeutics, Inc. was incorporated in 2018 and is based in Thousand Oaks, California. |
| Long Name | Latigo Biotherapeutics, Inc. |
| Market | us_market |
| Market Cap | 1,532,257,536 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_672821642 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | -111,176,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 1,580,950,750 |
| Open | 25.21 |
| Operating Cashflow | -103,469,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 805 716 2927 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 24.23 |
| Post Market Time | 1,787,959,806 |
| Previous Close | 25.0 |
| Price Hint | 2 |
| Price To Book | -0.5701981 |
| Profit Margins | 0.0 |
| Quick Ratio | 2.911 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.77 |
| Regular Market Change Percent | -3.08 |
| Regular Market Day High | 25.62 |
| Regular Market Day Low | 24.23 |
| Regular Market Day Range | 24.23 - 25.62 |
| Regular Market Open | 25.21 |
| Regular Market Previous Close | 25.0 |
| Regular Market Price | 24.23 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 217,740 |
| Sand P52 Week Change | 0.20204377 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 63,238,030 |
| Shares Percent Shares Out | 0.0021 |
| Shares Short | 134,468 |
| Short Name | Latigo Biotherapeutics, Inc. |
| Short Ratio | 0.16 |
| Source Interval | 15 |
| State | CA |
| Symbol | LTGO |
| Total Cash | 42,177,000 |
| Total Cash Per Share | 7.096 |
| Total Debt | 554,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -2.47 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 21.0125 |
| Two Hundred Day Average Change | 3.2174988 |
| Two Hundred Day Average Change Percent | 0.15312308 |
| Type Disp | Equity |
| Volume | 217,740 |
| Website | https://latigobio.com |
| Zip | 91,320 |